ABBV

$264.96 1.63% $4.26
Aug 21, 2026 04:00 AM

ABBV, or AbbVie Inc., is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex diseases.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Enhance Your ABBV Trading Now

Transform your approach to trading with OHLCX execution platform. Our automated system offers detailed metrics and technical analysis for ABBV, tailored to enhance your trading performance. Start optimizing your trades today and elevate your strategy.

Take Action Now

Frequently Asked Questions

Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.

Historically, ABBV has demonstrated strong performance, particularly driven by its flagship products in immunology and oncology.

ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.

As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.

ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.

ABBV is managed through various therapeutic areas, including immunology, oncology, neuroscience, and virology, with a strong emphasis on research and development.

Investors can purchase shares of ABBV through a brokerage account, as it is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."

Similar companies include Pfizer, Merck, and Johnson & Johnson, which also focus on pharmaceuticals and biopharmaceuticals.

Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.

Yes, ABBV can be held in retirement accounts such as IRAs or 401(k)s, making it a suitable choice for long-term investment strategies.

Supercharge Your ABBV Trading Now

Revolutionize your investment in ABBV with OHLCX Platform’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Boost your investment success with us with OHLCX Platform now and achieve better trading outcomes!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.